市場調查報告書
商品編碼
1423586
2030 年果凍市場預測:按產品類型、手術、應用、最終用戶和地區進行的全球分析Microsurgery Market Forecasts to 2030 - Global Analysis By Product Type (Operating Microscopes, Microsurgery Needle Holder, Micro Forceps, Micro Sutures and Other Product Types), Procedure, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球果凍市場規模為 22.4 億美元,預計預測期內複合年成長率為 7.2%,到 2030 年將達到 36.5 億美元。
果凍是一種高度專業化的外科手術,使用精緻的縫線、顯微鏡等放大設備和精密儀器對極小的身體部位進行手術。外科醫生經常對肉眼看不見的微小解剖特徵進行複雜的手術,例如脆弱的組織、血管和神經。此外,果凍技術的精確性需要執行這些技術的外科醫師經過特殊的訓練和能力。這些技術包括使用超細針和縫合線進行精確縫合、對細節的仔細關注以及精細的組織操作。
根據美國國家醫學圖書館2021年6月發表的研究結果,在放大鏡下進行牙根覆蓋的果凍技術優於傳統果凍技術,可減少牙齦厚度和患者滿意度。發現果凍部位癒合得更快。
慢性病增加
心血管疾病、糖尿病、癌症和神經系統疾病等慢性疾病通常需要複雜且精確的手術介入。果凍在這些疾病的治療中發揮重要作用。顯微果凍手術可以減少創傷、縮短恢復時間並改善患者的治療效果。果凍市場受益於患者和外科醫生對微創手術的日益偏好。
將新的果凍技術整合到現有的醫療保健系統中
將新的果凍技術涵蓋現有的醫療保健系統需要大量的規劃和實施。這些技術必須與目前的基礎設施整合,例如手術室、電子健康記錄(EHR) 系統和其他手術設備。這種複雜性會導致實施階段的延誤和額外成本。此外,不同技術和軟體平台之間可能會出現相容性問題,導致效率低下和資料管理挑戰,從而阻礙市場成長。
外科手術技術不斷進步
技術的發展顯著提高了果凍手術的精確度和可視性,特別是在手術顯微鏡、顯像模式和儀器方面。材料科學領域的不斷發展正在創造可改善手術效果的特定儀器和材料。例如,由現代合金和複合材料製成的顯微外科器械更俱生物相容性、耐用性和精確性,所有這些都提高了治療過程中的有效性。
高成本
與專業果凍設備、儀器和培訓相關的巨額成本可能會限制果凍的普及。較小的醫療機構,特別是在資源匱乏地區和發展中國家,可能難以承擔初始投資和持續成本,從而限制了這些地區果凍服務的可用性。事實確實如此。這種負擔可能會限制果凍領域發展的資金分配和最尖端科技的投資,從而影響醫療保健的整體品質。
COVID-19 的影響
COVID-19 大流行對果凍市場產生了重大影響,在各方面造成了干擾。由於醫療機構優先分配資源來應對這一流行病,選擇性果凍手術顯著減少,導致手術延遲和患者數量減少。由於製造限制和物流挑戰,供應鏈中斷影響了專用果凍器械和手術顯微鏡的可得性。嚴格的安全通訊協定和手術期間使用個人防護設備(PPE) 成為強制性要求,影響了手術的工作流程。
手術顯微鏡領域預計將成為預測期內最大的市場
由於光學元件、高解析度相機和照明系統等可實現放大和擴大視野的功能,顯微果凍中使用的手術顯微鏡預計將出現良好的成長。這些顯微鏡為醫生提供了手術部位清晰、完整的視圖,從而實現精確、系統化的手術。這些顯微鏡廣泛用於醫療領域,包括婦科、泌尿系統、神經科、眼科、整形外科、骨科和耳鼻喉科。這有利於市場拓展。
神經果凍領域預計在預測期內複合年成長率最高。
果凍果凍領域預計在預測期內複合年成長率最高,因為它涵蓋了影響大腦、脊髓、神經及其周圍組織的各種手術。在此類手術中,具有先進光學元件、高放大倍率和照明功能的高品質手術顯微鏡對於觀察和處理小型神經結構至關重要。這些顯微鏡提高了神經外科醫生的視力,使他們能夠精確地進行複雜的手術。
由於其高度發達的醫療保健系統、高感染疾病率、眾多大型國家臨床實驗室以及方便獲得最尖端科技,北美在預測期內佔據最大的市場佔有率。此外,由於患者群體擴大、社會意識提高以及外科醫生使用手術顯微鏡的監管核准,對感染疾病診斷套件的需求不斷增加,也推動了該地區的市場成長。
預計亞太地區在預測期內的複合年成長率最高。這是由於老年人口數量不斷增加,他們更有可能遇到與慢性病相關的問題。由於行業巨頭缺乏創新,獨立的新業務正在進入市場,提供高品質且價格合理的產品,增加可支配收入並擴大醫療保健的覆蓋範圍,正在推動市場成長。
According to Stratistics MRC, the Global Microsurgery Market is accounted for $2.24 billion in 2023 and is expected to reach $3.65 billion by 2030 growing at a CAGR of 7.2% during the forecast period. Microsurgery is a highly specialized surgical procedure that uses delicate sutures, magnifying equipment such as microscopes, and precise instruments to operate on minuscule bodily components. Surgeons may carry out complex operations on fragile tissues, blood vessels, nerves, and other microscopic anatomical features that are sometimes invisible to the unaided eye. Moreover, the precise nature of microsurgery techniques needs particular training and abilities for surgeons conducting them. Techniques include precision suturing using ultra-fine needles and sutures, careful attention to detail, and sensitive tissue manipulation.
According to a research study published by the National Library of Medicine in June 2021, under magnification, the microsurgical method for root coverage was found to be superior to the traditional microsurgical approach, and in addition to enhanced gingival thickness and patient satisfaction ratings, neovascularization at the microsurgical sites healed more quickly.
Rising prevalence of chronic diseases
Chronic diseases such as cardiovascular disorders, diabetes, cancer, and neurological conditions often necessitate complex and precise surgical interventions. Microsurgery plays a crucial role in treating these conditions. Minimally invasive surgeries, facilitated by microsurgical techniques and instruments, offer reduced trauma, quicker recovery times, and improved patient outcomes. The market for microsurgery benefits from this trend as it aligns with the increasing preference for less invasive approaches among patients and surgeons.
Integrating new microsurgical technologies into existing healthcare systems
Incorporating new microsurgical technologies into existing healthcare systems requires significant planning and execution. It involves integrating these technologies with the current infrastructure, including operating rooms, electronic health records (EHR) systems, and other surgical equipment. This complexity can lead to delays and additional expenses during the implementation phase. Moreover, compatibility issues between different technologies or software platforms may arise, leading to inefficiencies and data management challenges hamper the growth of the market.
Growing technological advances in surgical procedures
Technological developments have greatly enhanced precision and visibility during microsurgical procedures, especially with regard to operating microscopes, imaging modalities, and instruments. Continuous developments in the field of materials science have resulted in the creation of specific tools and materials that enhance surgical results. Microsurgical instruments composed of modern alloys or composite materials, for example, have improved biocompatibility, endurance, and accuracy, all of which boost their effectiveness during treatments.
High cost
The significant expenses related to specialized microsurgical equipment, instruments, and training can limit accessibility to microsurgery. Smaller healthcare facilities, especially in resource-constrained regions or developing countries, may struggle to afford the initial investment and ongoing costs, leading to limited availability of microsurgical services in these areas. This strain may limit the allocation of funds for the development of microsurgical departments or investment in cutting-edge technologies, impacting overall healthcare quality.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the microsurgery market, causing disruptions across various fronts. Elective microsurgical procedures experienced a substantial decline as healthcare facilities prioritized resources for pandemic response, leading to postponed surgeries and reduced patient volumes. Supply chain disruptions affected the availability of specialized microsurgical instruments and operating microscopes due to manufacturing constraints and logistical challenges. Stringent safety protocols and increased utilization of personal protective equipment (PPE) during surgeries became imperative, influencing procedural workflows.
The operating microscopes segment is expected to be the largest during the forecast period
Operating microscopes used in microsurgery are expected to have a lucrative growth due to characteristics such as enhanced optics, high-resolution cameras, and illumination systems that provide magnification and increased vision. They give doctors clear, thorough views of the surgical site, enabling them to perform precise, systematic procedures. These microscopes are used in a wide range of medical specialties, such as gynecology, urology, neurology, ophthalmology, plastic surgery, orthopedics, and ENT. This promotes market expansion.
The neurological microsurgeries segment is expected to have the highest CAGR during the forecast period
The neurological microsurgeries segment is anticipated to witness the highest CAGR growth during the forecast period, as a broad variety of operations affecting the brain, spinal cord, nerves, and surrounding tissues are included in the field of neurological microsurgery. For these operations, high-quality operating microscopes with sophisticated optics, strong magnification, and lighting capabilities are crucial for seeing and working with small neurological structures. These microscopes improve sight for neurosurgeons, allowing them to precisely execute complex surgery.
North America is projected to hold the largest market share during the forecast period because of its highly developed healthcare system, high incidence of infectious illnesses, numerous big national clinical labs, and convenient access to cutting-edge technology. Moreover due to the increased demand for infectious disease diagnostic kits brought on by an expanding patient pool and growing public awareness and approval from regulatory bodies for the use of surgical microscopes by surgeons is also responsible for driving the market's growth in the region.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the surge is attributed to an increase in the senior population, who are more likely to experience issues related to chronic illnesses. Due to the lack of innovation from the industry's major players, new, independent businesses have entered the market and are offering high-quality, reasonably priced items thus rising disposable income, and expanding access to healthcare encourage the growth of the market
Key players in the market
Some of the key players profiled in the Microsurgery Market include Scanlan International, Olympus Corp., HAAG-STREIT GROUP, Accurate Surgical & Scientific Instruments Corp., Surtex Instruments Ltd., KLS Martin Group, Topcon Corp., Integra LifeSciences, B. Braun Melsungen Inc., Leica Microsystems, Carl Zeiss AG, Medtronic, Novartis AG, Baxter, Halma PLC, Peter LAZIC GmbH, Danaher, SYNOVIS MICRO COMPANIES ALLIANCE and AROSurgical Instruments
In December 2023, Integra LifeSciences Announces Definitive Agreement To Acquire Acclarent®. The acquisition will become part of Integra's Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the neurosurgery segment.
In November 2023, Medtronic announces FDA approval of minimally invasive device to treat hypertension. With this approval, Medtronic will immediately begin commercialization.
In May 2023, Medtronic to acquire wearable insulin patch maker EOFlow, this acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support.